Alder BioPharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize therapeutic antibodies with the potential to meaningfully transform current treatment paradigms.

ALD403

ALD403 and Migraine

Newswire

ClinicalTrials

Current trials
Menu
×